Kohshi Nishiguchi

Medicine · Health Sciences

20h-index1.4kcitations87works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug Transport and Resistance Mechanisms(21), Pharmacological Effects and Toxicity Studies(11), Gastric Cancer Management and Outcomes(9), Pharmacogenetics and Drug Metabolism(8), Esophageal Cancer Research and Treatment(8)

Publications87 total

Effect of AST-120 treatment discontinuation and serum albumin on free and bound indoxyl sulphate in end-stage kidney disease
International Journal of Clinical Pharmacology and Therapeutics·2026
Association between antibody-dependent cellular cytotoxicity activity of antitumor antibodies and infusion reactions: a pharmacovigilance analysis using the Japanese adverse drug event report database
Journal of Pharmaceutical Health Care and Sciences·2025Open Access
Risk Factors for Infusion Reactions in Patients with Breast Cancer Administered Trastuzumab Therapy
Biological and Pharmaceutical Bulletin·2023· 4 citedOpen Access
Incidence and risk factors of infusion reactions in patients with breast cancer administered trastuzumab plus pertuzumab-based regimen
Cancer Chemotherapy and Pharmacology·2022· 5 cited
Research on the relationship between serum indoxyl sulfate concentration and iron dynamics index in patients with end-stage kidney disease: a cross-sectional study
Renal Replacement Therapy·2022· 1 citedOpen Access
Incidence and risk factors of infusion reactions in patients with breast cancer administered pertuzumab combination chemotherapy
Research Square (Research Square)·2022Open Access
Incidence and Risk Factors of Infusion Reactions in Breast Cancer Patients Administered Pertuzumab Combination Chemotherapy
Research Square (Research Square)·2022Open Access
Optimal Sampling Strategy and Threshold of Serum Vancomycin Concentration in Elderly Japanese Patients Undergoing High-Flux Hemodialysis
Therapeutic Drug Monitoring·2021· 1 cited
In Vitro Evidence of Potential Interactions between CYP2C8 and Candesartan Acyl-β-D-glucuronide in the Liver
Drug Metabolism and Disposition·2021· 4 citedOpen Access
Factors Associated with Dose Modification of Lenalidomide Plus Dexamethasone Therapy in Multiple Myeloma
Biological and Pharmaceutical Bulletin·2020· 1 citedOpen Access
Olaparib Potentiates Anticancer Drug Cytotoxicity <i>via</i> 53BP1 in Oesophageal Squamous Cell Carcinoma Cells
Anticancer Research·2020· 9 citedOpen Access
A case of idiosyncratic liver injury after oxaliplatin‐induced thrombocytopenia
Journal of Clinical Pharmacy and Therapeutics·2019· 5 cited
Uremic serum residue decreases SN-38 sensitivity through suppression of organic anion transporter polypeptide 2B1 in LS-180 colon cancer cells
Scientific Reports·2019· 3 citedOpen Access
Synergistic Effects of Olaparib and DNA-damaging Agents in Oesophageal Squamous Cell Carcinoma Cell Lines
Anticancer Research·2019· 18 citedOpen Access
Effects of Uremic Serum Residue on OATP1B1‐ and OATP1B3‐Mediated Pravastatin Uptake in OATP‐Expressing HEK293 Cells and Human Hepatocytes
Therapeutic Apheresis and Dialysis·2018· 5 cited
Histone deacetylase inhibitors sensitize 5‑fluorouracil‑resistant MDA‑MB‑468 breast cancer cells to 5‑fluorouracil
Oncology Letters·2018· 14 citedOpen Access
Concomitant administration of candesartan cilexetil in patients on paclitaxel and carboplatin combination therapy increases risk of severe neutropenia
International Journal of Clinical Pharmacology and Therapeutics·2018· 3 cited
Augmentation of the cytotoxic effects of nitrogen-containing bisphosphonates in hypoxia
Journal of Pharmacy and Pharmacology·2018· 2 cited
Acceleration of carboxylesterase-mediated activation of irinotecan to SN-38 by serum from patients with end-stage kidney disease
Cancer Chemotherapy and Pharmacology·2018· 4 cited
Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices
PLoS ONE·2018· 40 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Toshiyuki Sakaeda(26), Katsuhiko Okumura(18), Tsutomu Nakamura(15), Masayuki Tsujimoto(14), Tetsuya Minegaki(13), Noboru Okamura(11), Akiko Kuwahara(11), Motohiro Yamamori(11), Fusao Komada(10), Takao Tamura(8), Yusuke Tanigawara(8), Kohji Takara(8), Tatsuya Okuno(6), Ikuya Miki(6), Seigo Iwakawa(6), Mikio Kakumoto(5), Taku Furukubo(5), Satoshi Izumi(5), Tomoyuki Yamakawa(5), Koichi Iwaki(4)